- Home
- LEGN vs CELH Comparison
LEGN vs CELH Comparison
Compare LEGN & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- CELH
- Stock Information
- Founded
- LEGN 2014
- CELH 2004
- Country
- LEGN United States
- CELH United States
- Employees
- LEGN N/A
- CELH N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- CELH Beverages (Production/Distribution)
- Sector
- LEGN Health Care
- CELH Consumer Staples
- Exchange
- LEGN Nasdaq
- CELH Nasdaq
- Market Cap
- LEGN 7.0B
- CELH 7.5B
- IPO Year
- LEGN 2020
- CELH N/A
- Fundamental
- Price
- LEGN $27.80
- CELH $38.94
- Analyst Decision
- LEGN Strong Buy
- CELH Buy
- Analyst Count
- LEGN 13
- CELH 17
- Target Price
- LEGN $75.67
- CELH $47.41
- AVG Volume (30 Days)
- LEGN 1.6M
- CELH 7.0M
- Earning Date
- LEGN 05-13-2025
- CELH 05-06-2025
- Dividend Yield
- LEGN N/A
- CELH N/A
- EPS Growth
- LEGN N/A
- CELH N/A
- EPS
- LEGN N/A
- CELH 0.32
- Revenue
- LEGN $728,303,000.00
- CELH $1,329,198,000.00
- Revenue This Year
- LEGN $65.96
- CELH $57.42
- Revenue Next Year
- LEGN $52.55
- CELH $21.56
- P/E Ratio
- LEGN N/A
- CELH $119.85
- Revenue Growth
- LEGN 112.46
- CELH N/A
- 52 Week Low
- LEGN $29.27
- CELH $21.10
- 52 Week High
- LEGN $60.87
- CELH $98.85
- Technical
- Relative Strength Index (RSI)
- LEGN 29.31
- CELH 65.75
- Support Level
- LEGN $30.25
- CELH $32.36
- Resistance Level
- LEGN $33.30
- CELH $36.16
- Average True Range (ATR)
- LEGN 1.72
- CELH 1.73
- MACD
- LEGN -0.41
- CELH 0.14
- Stochastic Oscillator
- LEGN 3.14
- CELH 86.81
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.